PEPT2 is an integral membrane protein in the apical membrane of renal epithelial cells that operates as a rheogenic transporter for di-and tripeptides and structurally related drugs. Its prime role is thought to be the reabsorption of filtered di-and tripeptides contributing to amino acid homeostasis. To elucidate the role of PEPT2 in renal amino acid metabolism we submitted kidney tissues of wildtype and a Pept2 proteins involved in glutathione (GSH) metabolism suggests that PEPT2 is predominantly a system for reabsorption of cys-gly originating from GSH break-down, thus contributing to resynthesis of GSH.
INTRODUCTION
Cellular uptake of di-and tripeptides is mediated in prokaryotes and eukaryotes by membrane proteins of the peptide transporter (PTR) family (36) . The peptide transporters PEPT1 (Slc15a1) and PEPT2 (Slc15a2) and the peptide/histidine transporters PHT1 (Slc15a4) and PHT2 (Slc15a3) form the two subgroups of proteins belonging to the PTR family in mammals. The PHT-proteins appear to transport primarily histidine but also selected di-and tripeptides. PHT-1 is found in brain, retina, skeletal muscle and kidney (7, 41) while PHT2 is expressed primarily in the lymphatic system but also in lung and placenta (33) .
In contrast to the PHT-proteins, PEPT1 and PEPT2 have been well characterized since their cloning a decade ago (5, 6, 13, 21 ) with a number of recent reviews summarizing current knowledge on structure and mode of transport function (12, 15, 30) . also expressed in kidney tubules and the bile duct. In contrast, PEPT2 is found in numerous organs with highest expression levels in kidney and lower expression in the nervous system, lung, mammary gland and choroid plexus. Expression in glial cells in the enteric nervous system of the gut has also been shown recently (32) . Although well understood in function at the molecular level, the physiological role of PEPT2 in the different organs in which it is expressed has not been well defined as yet.
In the kidney, peptides and amino acids are reabsorbed from the glomerular filtrate by the activities of peptide transporters and amino acid transporters acting in parallel in the apical membrane of tubular epithelial cells (for review see (1, 26) ). The localization of PEPT1 in the S1 segment of the proximal tubule and PEPT2 in the S2 and S3 segment has led to the concept that the high capacity transporter PEPT1 is responsible for the reabsorption of bulk quantities of peptides in the more proximal part whereas PEPT2 as the high affinity transporter acting in the more distal parts of the proximal tubule taking care of the remaining luminal substrates. Yet, early studies in rabbit brush border membrane vesicles already indicated that mainly a high affinity system (PEPT2) is responsible for the bulk uptake of di-and tripeptides in the tubule (20).
To assess the role of PEPT2 in renal peptide reabsorption a mouse model that lacks a functional PEPT2 protein has been generated (31) . Animals were proven to have severely impaired renal reabsorption of radiolabeled and fluorogenic model dipeptides confirming that PEPT2 plays the prominent role in renal dipeptide handling. Moreover, lack of PEPT2 did not lead to any compensatory upregulation of either PEPT1 or PHT1 transporters in kidney, neither at the mRNA or protein levels. Recent clearance studies with the dipeptide glycyl-sarcosine in Pept2 -/-and wildtype mice established that PEPT2
indeed accounts for 86% of overall renal peptide reabsorption (25). Mice lacking the peptide transporter PEPT2 nevertheless display only very little phenotypic alterations (14, 35) . To assess to which extent this lack of a prominent phenotype in Pept2 -/-mice is caused by biological redundancy, a comprehensive analysis of mRNA, protein and metabolite levels in the same kidney tissue samples of transporter-deficient and control animals was performed in combination with the assessment of urinary losses of amino acids and dipeptides.
MATERIALS AND METHODS

Animals and sample collection:
The generation of the PEPT2-deficient mice (Slc15a2
tm1Dan
) by targeted disruption of the Pept2 gene has been reported previously (31) and animals were bred on a mixed genetic background of C57/Bl6 and 129Sv. Homozygous animals of the Pept2 +/-line were mated to yield litters of entirely Pept2 +/+ or Pept2 -/-pups for the experiments.
Animals were maintained at 22 ± 2°C and a 12:12 hrs light/dark cycle with access to tap water and a standard rodent diet (Altromin, 1320, Detmold, Germany) ad libitum. The genotype of an animal was identified by PCR screening with a primer pair directed against the first intron of the Pept2 wildtype allele (forward Primer: 5'-cca ctg aaa ctg aca ccc ac-3', reverse Primer: 5'-gct ctg cac aca agg gaa ac-3'), which is replaced in the targeted allele, and with a primer pair directed against the lacZ cassette that is inserted in the targeted allele (forward Primer: 5'-cag gat atg tgg cgg at gag-3', reverse Primer:
5'-gtt caa cca ccg cac gat ag-3')
Tissue sampling for transcriptome, proteome and metabolome analysis: were fed a semi-synthetic purified diet formulated according to AIN-93G. At the age of 8 weeks mice were placed in metabolic cages that allowed collection of urine and monitoring of food and water consumption. For eighteen days mice had free access to food and tap water ad libitum. Bodyweight and consumption of food and water were monitored daily. On day 19-23 mice were placed in clean metabolic cages and food was removed for the 12 hours during the dark phase to allow for urine collection without any contamination of urine by food. Containers for urine collection were cooled and 10 µl of 10% thymol in isopropanol were added to avoid bacterial degradation of metabolites.
Urine samples were stored at -20°C until analyzed for free and dipeptide bound amino acids. Mice were killed by cervical dislocation on day 24 between 8 and 10 a.m. after the last urine collection period. Kidneys were removed and immediately snap frozen in liquid nitrogen.
Sample collection for determination of cys-gly in spot urine samples and GSH levels in kidney tissue: Spot urine samples of 10 animals per sex and genotype were collected at the age of 12 weeks on five consecutive days between 9.00 and 10.00 a.m. by mild pressure on the lower abdomen. Samples were immediately frozen and stored at -20°C until analysis. Kidney samples for determination of GSH were quickly removed after 
Microarray data analysis
Data were formatted according to MIAME standards and submitted to the Gene Expression Omnibus (GEO) database as series GSE1585 and GSE1586. For further analysis, intensity-dependent normalization was performed with the LOESS (42) procedure followed by subtraction of the log-ratio median calculated over the values for an entire block from each individual log-ratio using the anapuce package of R.
Differential analysis was performed with the varmixt package of R (10) 
Realtime-Reverse-Transcription PCR (qPCR)
Changes in transcript levels of genes identified as regulated in cDNA microarray 
Relative quantification was performed as described above.
Sample Preparation for Two-Dimensional Gel Electrophoresis (2D-PAGE)
Individual kidneys were homogenized in a mortar under liquid nitrogen, 50mg tissue were transferred into 500 µl lysis buffer (7 M urea, 2 M thiourea, 2% CHAPS, 1% DTT, 2% Pharmalyte, Complete Mini proteinase inhibitor) and homogenisation was achieved by ultrasonification (30 strokes, low amplitude) on ice. Lysed tissue samples were centrifuged for 30 min at 100 000 x g at 4°C and protein concentrations were determined by a modified Bradford assay (Bio-Rad protein assay). Protein extracts were dialysed with the Plusone Mini Dialysis Kit (Amersham) against a modified lysis buffer (7 M urea, 2 M thiourea, 1% DTT) and stored at -80 °C until analyzed.
2D-PAGE
2D-PAGE was performed as described by Fuchs et al. (15) . Briefly, 300 µg of protein were loaded by cuploading and IEF was performed on 18 cm IPG strips ( pH 3-10,
Amersham Biosciences, Freiburg, Germany) using an Amersham IPGPhor unit. 12.5%
SDS-polyacrylamid gels were run on an Amersham Bisosciences Ettan-Dalt II system in the second dimension. Gels were fixed and subsequently stained with Coomassie blue (CBB G-250, Serva, Heidelberg, Germany). 2 Gels were performed for every individual animal. Gels were scanned and analyzed using the ProteomWeaver software (Definiens Imaging GmbH, Munich, Germany), which combined the spot detection with automatic background subtraction and normalization of the spot volumes. Spots differing significantly (p < 0.05, double sided, unpaired Student's t-test) in density were picked for MALDI-TOF MS analysis.
Tryptic digestion of protein spots and peptide mass fingerprinting by Matrixassisted laser desorption/ionization-time of flight-mass spectrometry (MALDI-TOF-MS)
All methods applied here have been described in detail by Fuchs et al. (15) . Briefly, CBBstained spots were picked, destained and digested in gel with sequencing grade modified trypsin (Promega). The resulting peptide fragment extracts were analyzed by MALDI-TOF-MS with an Autoflex mass spectrometer (Bruker Daltonics, Leipzig, Germany). Proteins were identified with the Mascot Server 1.9 (Bruker Daltonics) based on mass searches with mouse sequences only. The criteria for positive identification of proteins were set as follows: (i) a minimum score of 63; (ii) mass accuracy of ± 0.01%
and (iii) at least two-fold analysis from four independent gels.
Metabolite profiling by gaschromatography-time of flight-mass spectrometry (GC-TOF-MS)
Metabolite levels in kidney tissue were analyzed as described in (39) GC-TOF-MS analysis was performed using a HP5890 gas chromatograph with standard liners containing glass wool in a splitless mode at 230°C injector temperature with a liner exchange for every 50 samples. The GC was operated at constant flow of 1 ml/min helium on a 30 m, 0.25 mm ID, 0.25 µm RTX-5 column with a 10 m integrated precolumn. The temperature gradient started at 80°C, was held isocratic for 2 min, and subsequently ramped at 15°C/min to a final temperature of 330°C which was held for 6 min. Data were acquired on a Pegasus II TOF mass spectrometer (LECO, St. Joseph, MI) and CHROMATOF 1.61 software at 20 s -1 from m/z 85-500, R = 1, 70 kV electron impact (EI) and auto-tuning with reference gas CF 43. Samples were compared against reference chromatograms that had a maximum of detectable peaks at signal/noise >20.
For identification and alignment, peaks were matched against a customized reference spectrum database, based on retention indices and mass spectral similarities. Relative quantification was performed on ion traces chosen by optimal selectivity from co-eluting compounds. Artifact peaks resulting from column bleeding, phtalates and polysiloxanes were removed. All data were normalized to tissue fresh weight (FW) and to internal references (ribitol and nonadecanoic acid methyl ester). Data were log-transformed, resulting in more Gaussian-type distributions. Differences between transporter-deficient and control animals were analyzed by principal component analysis (PCA) and partial least squares discriminant analysis (PLS-DA) after centering and unit variance (UV) scaling of the complete data set (identified and unidentified compounds) with SIGMA P (Umetrics Ltd., Umeå, Sweden). PLS-DA was cross-validated by leaving out 20% of the samples, calculating a new model on the remaining samples and predicting the class membership of the left out samples. This process was repeated five times.
Analysis of urinary free and dipeptide-bound amino acids
Urine samples of the metabolic study (n = 10-12 per genotype) were prepared for amino acid analysis in parallel with or without digestion by renal membrane dipeptidase (EC vitro hydrolysis of urinary dipeptides was performed by incubation of 200 µl urine with 500 ng dipeptidase for 30 min at 37°C. Amino acids were analyzed by ion-exchange chromatography with a Biotronic LC3000 amino acid analyzer (Eppendorf, Hamburg, Germany) employing a lithium borate/acetate buffer system and ninhydrin postcolumn detection. Data were used if duplicate analysis indicated reliable quantification resulting in analysis of an average of 6 -12 mice per genotype depending on the amino acid detected. The detection limit of the amino acids (defined as signal-to-noise ratio > 5)
was around 1 µmol/l and the recovery of amino acids added at known concentrations to urine samples varied between 93% and 110%. Creatinine was analysed with an Olympus AU400 autoanalyzer (Hamburg, Germany) with adapted reagents from Olympus (Hamburg, Germany) and Roche (Mannheim,Germany) and data on urinary amino acids are expressed in mmol/mol creatinine.
HPLC-based determination of Cys-Gly in urine and GSH in kidney tissue
Cys-Gly in urine and GSH in tissue extracts were determined by HPLC after derivatization with monobromobimane according to the method of Pastore et al. (27) with slight modifications. Briefly, 26 µl of sample were mixed with 26 µl of 4 M NaBH 4 (dissolved in a solution of 333ml/l DMSO and 66 mmol/l NaOH in water), 18. 
Statistical analysis
Statistical analyses of amino acids in urine, MNE-values of differentially expressed genes and thiols in urine and tissues were performed by SPSS Version 12.0.1. The level of statistical significance was set at p < 0.05. Values are given as the mean ± SEM. In case that Gaussian distribution was not given, nonparametric tests were applied.
RESULTS
Transcriptome analysis of kidney samples by cDNA microarrays
Differential gene expression in kidneys of Pept2 -/-and Pept2 +/+ animals was assessed with 20k cDNA microarrays (34). 159 genes did show significantly altered mRNA levels in the transporter-deficient animals. As 12 of these genes were represented by two predicted correctly by these training models for 9 out of 10 samples. Identified metabolites that contributed most to discrimination between genotypes are listed in Table 2 and revealed primarily lower levels of amino acids and amino acid derivatives in kidney samples of transporter-deficient animals.
2D-PAGE and MALDI-TOF analysis of kidney proteome
Urinary excretion of amino acids and dipeptides
Analysis of urine samples covered free amino acids and dipeptide-bound amino acids as determined by increases in free amino acids after in vitro hydrolysis of urine samples with a non-specific dipeptidase. Values for free amino acids and amino acids after dipeptidase hydrolysis are given in Table 3 . Urine in vitro hydrolysis led to significant increase in amino acid concentrations in the case of glycine and cystine in the transporter deficient animals, only, resulting in a significant difference of dipeptide-bound cystine and glycine between Pept2 -/-and Pept2 +/+ mice. As the main dipeptide-bound amino acids identified in urine were glycine and cystine we hypothetized that they are derived from cys-gly, a break-down product of glutathione (GSH, -glutamyl-cysteinylglycine). We therefore analyzed spot urine samples for cysteinyl-glycine by HPLC with a thiol-specific derivatization procedure. As shown in Fig. 1 , excretion of the dipeptide cysgly was increased 18-fold in male Pept2 -/-animals and 5-fold in female Pept2 -/-mice.
GSH concentration in kidney tissue and expression level of genes involved in GSH metabolism
As the excretion of the GSH breakdown product cysteinyl-glycine was drastically increased and levels of glycine and cysteine were lower in kidney tissue of transporter deficient animals, we hypothesized that the concentrations of GSH in the kidney might also be altered in Pept2 -/-animals due to an impaired supply of substrates for GSH synthesis. Analysis of GSH in kidney tissue by HPLC with thiol specific derivatization, however, revealed no significant differences between Pept2 +/+ (4.19 ± 0.24 µmol/g tissue) and Pept2 -/-(3.87 ± 0.11 µmol/g tissue) animals. Expression of enzymes involved in GSH metabolism was studied at mRNA levels by qPCR to assess whether changes in enzymes needed for GSH synthesis could compensate for a lower supply of substrates.
Yet, no significant changes in transcript levels were observed for any of the selected enzymes (Table 4) .
DISCUSSION
We here provide data of a comprehensive analysis of changes in kidney tissue samples (Table S2 ). In addition a number of enzymes of lipid and fatty acid metabolism (Table S3 ) such as carnitine-palmitoyltransferase 2 (Cpt2), long chain acyl CoA synthetase (Acsl1), acyl-CoA-thioesterase 3 (Acot3) and acetyl-CoA acyltransferase 1A and 1B (Acaa1a, Acaa1b) were found regulated. Although the Urine samples contained increased concentrations of cysteinyl-glycine and when amino acid levels in urine were analyzed after hydrolysis by the dipeptidase, again only glycine and cystine concentrations increased (Fig. 1, Table 3 ). These data provided evidence that the most prominent dipeptides that can be found in kidney tubular fluids are those consisting of glycine and cysteine residues and that the only one identified that shows drastically increased excretion rates in Pept2 -/-mice is cysteinyl-glycine. The increased excretion of amino acids and particular of cysteinyl-glycine by the transporter deficient animals did not result from increased plasma levels and thus a higher tubular load since plasma levels of amino acids and cysteinyl-glycine did not differ between Pept2 +/+ and
Pept2
-/-animals (data not shown). Urinary cysteinyl-glycine is most likely a product of the break-down of GSH as extracellular degradation of GSH by -glutamyl-transferase (Ggt1) leads to cysteinyl-glycine and -glutamyl-amino acids (9) . GSH is found in plasma with mean concentrations of 10 µM and reaches after glomerular filtration the tubular system in which also a GSH secretion takes place (19). In the tubule, GSH is then cleaved by Ggt1 into cysteinyl-glycine and a -glutamyl-amino acid. It can be anticipated that cysteinyl-glycine is normally cleaved further by membrane-bound dipeptidases and that the free amino acids are then reabsorbed for resynthesis of GSH in tubular cells.
How the -glutamyl-amino acids are taken up into epithelial cells is not understood as yet, but -glutamyl-amino acids can be metabolized within the cell by -glutamylcyclotransferase (Ggc) to oxoproline, which can be converted to glutamate by oxoprolinase (Oplah). Although -glutamyl-amino acids are not transported by PEPT2
(unpublished observations), we observed lower levels of oxoproline and increased mRNA levels of oxoprolinase in the transporter-deficient animals.
An alternative and most likely more important route for reabsorption of the GSH breakdown products is the uptake of cysteinyl-glycine via PEPT2 followed by intracellular hydrolysis to yield glycine and cysteine. Cys-gly has been shown to be a good substrate for PEPT2, and can be used efficiently for GSH synthesis (11) . The 18-fold increase in renal loss of cys-gly in male Pept2 -/-mice suggests that the uptake of the intact dipeptide is important for renal scavenging of the GSH constituents. It is interesting to note that two intracellular peptidases (Napsa, Xpnpep) and a cytosolic dipeptidase (Cndp2) were identified as regulated in expression level in Pept2 -/-mice which suggests that they could be involved in hydrolysis of cys-gly after its uptake into tubular cells or intracellular protein hydrolysis if cellular free amino acid levels are low. GSH is resynthesized in renal tubular cells from glutamate, cysteine and glycine via -glutamyl-cysteine by glutamylcysteine synthetase (consisting of the subunits Gclm and Gclc) and glutathione synthetase (Gss). Fig. 3 gives a schematic view of renal GSH metabolism and the proposed involvement of PEPT2. For assessing whether these enzymes needed for GSH re-synthesis showed any changes in expression levels in kidney tissues, qPCR amplifications of mRNA were performed but did not reveal any significant adaptations in transcript levels. Surprisingly, GSH levels determined by HPLC with thiol-specific derivatization also revealed no differences between control animals and transporterdeficient animals despite lower cellular concentrations of the precursor amino acids.
These unchanged GSH-levels however may be explained best by an increased uptake of GSH from the blood across the basolateral membrane of tubular cells. It has been suggested that the sodium-dicarboxylate transporter 2 (Sdct-2) and the organic anion transporters 1 (Oat1) and 3 (Oat3) mediate basolateral GSH uptake (19) and our cDNA microarray analysis revealed indeed increased mRNA levels for Oat3 as a putative GSH import system. Despite the lack of changes in tissue GSH levels, an up-regulation of the glutathione-transferases Gstt2 at the mRNA level and an up-regulation of Gstm1 at mRNA and protein level suggests that the GSH turnover of renal cells may not only be affected by the identified lower levels of the precursor amino acids in Pept2 -/-mice but also by its use for conjugation and detoxification employing the glutathione transferases.
Other changes in metabolic pathways of amino acids in tubular cells as based on the transcriptome, proteome and metabolite analysis data suggest that for example less ornithine is used for polyamine synthesis involving the identified Odc1 enzyme that could lead to the decreased levels of putrescine found. Identified transcripts for enzymes surrounding altered glutamate, alanine and pyruvate levels suggest that nitrogenshuttling may also be altered. Two regulated enzymes of the pathway that leads from glycine via -aminolevulinic acid to porphyrins (Alad and CPOX) suggest impairments in this metabolic route and in this context it is interesting to note that -aminolevulinic acid has been shown to be a good substrate of the peptide transporter PEPT2. Whether its renal uptake and metabolism is affected in Pept2 -/-mice, needs further studies.
In summary, kidneys of mice that lack the renal high affinity type peptide transporter Gclc, glutamylcysteine ligase catalytic subunit; Gclm, glutamylcysteine ligase modifier subunit; Ggc, -glutamyl-cyclotransferase; Ggt1, -glutamyl-transferase; Gss, glutathione synthetase; Gstm1, glutathione S-transferase mu1; Gstt2, glutathione Stransferase theta 2; Mrp2, multidrug resistance-associated protein 2; Mrp4, multidrug resistance-associated protein 4; Oat1, organic anion transporter 1; Oat3, organic anion transporter 3; Oatp1, organic anion transporting polypeptide 1; Oplah, 5-oxoprolinase;
Sdct-2, sodium-dicarboxylate transporter 2 Identified and unidentified compounds analyzed by GC-TOF-MS were examined by partial least squares discriminant analysis (PLS-DA) to identify compounds that contribute most to differentiation between knockout and wildtype kidney tissue.
1 Identified metabolites that contributed most to class prediction (Pept2 -/-/ Pept2 +/+ ) 2 Ratio of mean concentrations levels, n = 5 per genotype 
